- • Up to 20% off your first purchase
- • Bulk quantities available
- • Citation Reward application
Sample Application
Supports
- Talk to our Expert:
[email protected] -
Talk to our sales:
[email protected]
Protocol Library
 |
 |
Hepatitis B s antigen (HBsAg) (HBsAg (hepatitis B surface antigen)) antibody and antigen (Recombinant protein)
Diagnostic antibodies (anti-Hepatitis B s antigen (HBsAg), anti-HBsAg (hepatitis B surface antigen)) and antigens (recombinant protein) for Infectious disease HBsAg (hepatitis B surface antigen) detection in ELISA, colloidal gold-based Lateral flow immunoassay (LFIA), CLIA, TINIA and POCT.
Go to
Neurodegenerative diseases diagnostics
products collection
>>
Product information
| Catalog No. | Description | US $ Price (per mg) |
|---|---|---|
| GMP-IVD-P029-Tg001-Ag01 | Recombinant human Hepatitis b virus (HBV) HBsAg (hepatitis B surface antigen) Protein | 3090 |
| GMP-IVD-P029-Tg001-Ab01 | Anti-human Hepatitis b virus (HBV) HBsAg (hepatitis B surface antigen) mouse monoclonal antibody (mAb) | 1953 |
| GMP-IVD-P029-Tg001-Ab02 | Anti-human Hepatitis b virus (HBV) HBsAg (hepatitis B surface antigen) mouse monoclonal antibody (mAb) | 1953 |
| GMP-IVD-P029-Tg001-Ab03 | Anti-human Hepatitis b virus (HBV) HBsAg (hepatitis B surface antigen) human monoclonal antibody (mAb) | 1953 |
| GMP-IVD-P029-Tg001-Ab04 | Anti-human Hepatitis b virus (HBV) HBsAg (hepatitis B surface antigen) human monoclonal antibody (mAb) | 1953 |
Size： 1mg | 10mg | 100mg
Product Description
| Cat No. of Products | GMP-IVD-P029-Tg001-Ag01 |
| Product Name | Recombinant human Hepatitis b virus (HBV) HBsAg (hepatitis B surface antigen) Protein |
| Pathogen | Hepatitis b virus |
| Target/Biomarker | Hepatitis B s antigen (HBsAg)(HBsAg (hepatitis B surface antigen)) |
| Expression platform | E.coli |
| Isotypes | Recombinant Antigen |
| Bioactivity validation | Hepatitis B s antigen (HBsAg) (HBsAg (hepatitis B surface antigen)) antibodies binding, Immunogen in Sandwich Elisa, lateral-flow tests, and other immunoassays as control material in HBsAg (hepatitis B surface antigen) level test of Infectious disease (Hepatitis B) and related syndrome evaluation. |
| Tag | His |
| Products description | Recombinant human Hepatitis b virus (HBV) HBsAg (hepatitis B surface antigen) Protein was expressed in E.coli - based prokaryotic cell expression system and is expressed with 6 HIS tag at the C-terminus. |
| Purity | Purity: ≥95% (SDS-PAGE) |
| Application | Standard substance, positive control, ELISA test,Lateral flow immunoassay (LFIA),colloidal gold immunochromatographic assay, Chemiluminescent immunoassay (CLIA),turbidimetric inhibition immuno assay (TINIA),immunonephelometry and POCT. |
| Formulation | Supplied as a 0.2 μM filtered solution of PBS,PH7.4. |
| Storage | Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles. |
| Cat No. of Products | GMP-IVD-P029-Tg001-Ab01, GMP-IVD-P029-Tg001-Ab02 |
| Product Name | Anti-human Hepatitis b virus (HBV) HBsAg (hepatitis B surface antigen) mouse monoclonal antibody (mAb) |
| Pathogen | Hepatitis b virus |
| Target/Biomarker | Hepatitis B s antigen (HBsAg)(HBsAg (hepatitis B surface antigen)) |
| Expression platform | CHO |
| Isotypes | Mouse IgG |
| Bioactivity validation | Human Hepatitis B s antigen (HBsAg) (HBsAg (hepatitis B surface antigen)) antigen binding, ELISA validated as capture antibody and detection antibody. Pair recommendation with other Hepatitis B s antigen (HBsAg) (HBsAg (hepatitis B surface antigen)) antibodies in HBsAg (hepatitis B surface antigen) level test of Infectious disease (Hepatitis B) and related syndrome evaluation. |
| Tag | mFc |
| Products description | Anti-human Hepatitis b virus (HBV) HBsAg (hepatitis B surface antigen) mouse monoclonal antibody (mAb) is a monoclonal antibody produced by CHO. The antibody is ELISA validated as capture antibody and detection antibody pair. |
| Purity | Purity: ≥95% (SDS-PAGE) |
| Application | ELISA test, Lateral flow immunoassay (LFIA), colloidal gold immunochromatographic assay, Chemiluminescent immunoassay (CLIA), turbidimetric inhibition immuno assay (TINIA), immunonephelometry and POCT. |
| Formulation | Supplied as a 0.2 μM filtered solution of PBS,PH7.4. |
| Storage | Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles. |
| Cat No. of Products | GMP-IVD-P029-Tg001-Ab03, GMP-IVD-P029-Tg001-Ab04 |
| Product Name | Anti-human Hepatitis b virus (HBV) HBsAg (hepatitis B surface antigen) human monoclonal antibody (mAb) |
| Pathogen | Hepatitis b virus |
| Target/Biomarker | Hepatitis B s antigen (HBsAg)(HBsAg (hepatitis B surface antigen)) |
| Expression platform | CHO |
| Isotypes | Human IgG1 |
| Bioactivity validation | Human Hepatitis B s antigen (HBsAg) (HBsAg (hepatitis B surface antigen)) antigen binding, ELISA validated as capture antibody and detection antibody. Pair recommendation with other Hepatitis B s antigen (HBsAg) (HBsAg (hepatitis B surface antigen)) antibodies in HBsAg (hepatitis B surface antigen) level test of Infectious disease (Hepatitis B) and related syndrome evaluation. |
| Tag | hFc |
| Products description | Anti-human Hepatitis b virus (HBV) HBsAg (hepatitis B surface antigen) human monoclonal antibody (mAb) is a monoclonal antibody produced by CHO. The antibody is ELISA validated as capture antibody and detection antibody pair. |
| Purity | Purity: ≥95% (SDS-PAGE) |
| Application | ELISA test, Lateral flow immunoassay (LFIA), colloidal gold immunochromatographic assay, Chemiluminescent immunoassay (CLIA), turbidimetric inhibition immuno assay (TINIA), immunonephelometry and POCT. |
| Formulation | Supplied as a 0.2 μM filtered solution of PBS,PH7.4. |
| Storage | Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles. |
Reference
Validation Data
Click to get more Data / Case study about the product.
Target/Biomarker information
Hepatitis B is a viral infection that attacks the liver and can cause both acute and chronic disease. The virus is most commonly transmitted from mother to child during birth and delivery, as well as through contact with blood or other body fluids during sex with an infected partner, unsafe injections or exposures to sharp instruments.
About GDU
GDU helps global diagnostic partners in high quality of raw material discovery, development, and application. GDU believes in Protein&antibody Innovation for more reliable diagnostic solutions.
Facebook
LinkedIn
Twitter
Comments